Actively Recruiting
Study of Indocyanine Green ICG Dye to Improve Tumor Detection During Surgery for Head and Neck Squamous Cell Carcinoma Phase 2 Diagnostic Trial in Adults
Led by Medical University of South Carolina · Updated on 2026-07-07
30
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial is designed for adults with squamous cell carcinoma of the head and neck who face a risk of cancer recurrence. The study aims to evaluate if using Indocyanine Green ICG dye during surgery can improve the identification of tumor tissue, potentially enhancing the surgical process. It is a Phase 2 interventional trial sponsored by the Medical University of South Carolina. Participants will receive a 5 mgkg intravenous injection of ICG dye before surgery. The procedure involves imaging during the operation to help visualize tumor tissue better. This is a single-arm trial without a comparison group, focusing on the diagnostic use of ICG. The study period lasts about 6 weeks, including surgery and follow-up for pathology results. During the study, participants will undergo standard care visits along with surgery where ICG imaging is performed. Researchers will assess the sensitivity and specificity of ICG imaging from surgery until final pathology results are available, which takes about 2 weeks. Additional assessments of white light visualization and changes in visualization using specific dimensions will also be made. Participants will be monitored throughout this period to collect safety and diagnostic data.
CONDITIONS
Brief Title
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Research Team
H
HCC Clinical Trials Office
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here